{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:07:36Z","timestamp":1791511656425,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bioorg.2023.106976","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:03:51Z","timestamp":1700345031000},"page":"106976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Boron-containing carbonic anhydrases inhibitors"],"prefix":"10.1016","volume":"143","author":[{"given":"Simone","family":"Giovannuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nikitjuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Rafaela","family":"Pereira Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Smietana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Winum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106976_b0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/ph15030264","article-title":"The boron advantage: the evolution and diversification of boron's applications in medicinal chemistry","volume":"15","author":"Messner","year":"2022","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.bioorg.2023.106976_b0010","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3390\/molecules27092615","article-title":"Boron chemicals in drug discovery and development: synthesis and medicinal perspective","volume":"27","author":"Das","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106976_b0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/17460441.2016.1174687","article-title":"Recent developments with boron as a platform for novel drug design","volume":"11","author":"Le\u015bnikowski","year":"2016","journal-title":"Expert Opin. Drug. Discov."},{"key":"10.1016\/j.bioorg.2023.106976_b0020","series-title":"Boron-Based Compounds: Potential and Emerging Applications in Medicine","year":"2018"},{"key":"10.1016\/j.bioorg.2023.106976_b0025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejmech.2019.06.092","article-title":"Boron in drug design: Recent advances in the development of new therapeutic agents","volume":"179","author":"Fernandes","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/tcr.201402100","article-title":"Boron-based drug design","volume":"15","author":"Ban","year":"2015","journal-title":"Chem. Rec."},{"key":"10.1016\/j.bioorg.2023.106976_b0035","doi-asserted-by":"crossref","first-page":"13629","DOI":"10.1039\/D1CC05481C","article-title":"The modern role of boron as a 'magic element' in biomedical science: chemistry perspective","volume":"57","author":"Chatterjee","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2023.106976_b0040","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/molecules25040828","article-title":"Boron Chemistry for Medical Applications","volume":"25","author":"Ali","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2023.106976_b0045","series-title":"The Toxicity of Environmental Pollutants","article-title":"Boron and boron-containing compounds toxicity","author":"Sevim","year":"2022"},{"key":"10.1016\/j.bioorg.2023.106976_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116748","article-title":"Boron-Containing heterocycles as promising pharmacological agents","volume":"63","author":"Das","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0055","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4155\/fmc.09.71","article-title":"Therapeutic potential of boron-containing compounds","volume":"1","author":"Baker","year":"2009","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0060","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.apsb.2021.01.010","article-title":"Recent developments in the medicinal chemistry of single boron atom-containing compounds","volume":"11","author":"Song","year":"2021","journal-title":"Acta Pharm Sin b."},{"key":"10.1016\/j.bioorg.2023.106976_b0065","series-title":"Boron in cancer therapeutics: An overview","author":"Kulkarni","year":"2023"},{"key":"10.1016\/j.bioorg.2023.106976_b0070","first-page":"135","article-title":"Boron and covalent inhibition","volume":"56","author":"Leach","year":"2021","journal-title":"Annu Rep Med Chem"},{"key":"10.1016\/j.bioorg.2023.106976_b0075","doi-asserted-by":"crossref","first-page":"2220084","DOI":"10.1080\/14756366.2023.2220084","article-title":"Organoboronic acids\/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope","volume":"38","author":"Al-Omari","year":"2023","journal-title":"J Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0080","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4155\/fmc-2021-0222","article-title":"Novel carbonic anhydrase inhibitors","volume":"13","author":"Supuran","year":"2021","journal-title":"Future Med Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0085","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin Sci (lond)."},{"key":"10.1016\/j.bioorg.2023.106976_b0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/14756360127572","article-title":"Carbonic anhydrase inhibitors: allylsulfonamide, styrene sulfonamide, N-allyl sulfonamides and some of their Si, Ge, and B derivatives","volume":"16","author":"Chazalette","year":"2001","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2023.106976_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14756360109162362","article-title":"Carbonic anhydrase inhibitors, interaction of boron derivatives with isozymes I and II: A new binding site for hydrophobic inhibitors at the entrance of the active site as shown by docking studies","volume":"16","author":"Chazalette","year":"2001","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2023.106976_b0100","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.bmc.2009.03.058","article-title":"Carbonic anhydrase inhibitors. inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids","volume":"17","author":"Winum","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0105","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.bmcl.2009.03.147","article-title":"Carbonic anhydrase inhibitors. inhibition of the fungal \u03b2-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids","volume":"19","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0110","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.bmcl.2005.04.058","volume":"15","author":"Winum","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0115","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1016\/j.bmcl.2010.04.114","article-title":"Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV","volume":"20","author":"Di Fiore","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0120","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.bmcl.2011.03.055","article-title":"Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII","volume":"21","author":"Rami","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0125","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/cbic.202100121","article-title":"Inhibitors of CA IX enzyme based on polyhedral boron compounds","volume":"22","author":"Kugler","year":"2021","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2023.106976_b0130","doi-asserted-by":"crossref","first-page":"14005","DOI":"10.1002\/ange.201307583","article-title":"Carborane-Based Carbonic Anhydrase Inhibitors","volume":"125","author":"Brynda","year":"2013","journal-title":"Angew. Chem. Intl. Ed."},{"key":"10.1016\/j.bioorg.2023.106976_b0135","doi-asserted-by":"crossref","first-page":"16096","DOI":"10.1021\/jp410216m","article-title":"QM\/MM calculations reveal the different nature of the interaction of two carborane-based sulfamide inhibitors of human carbonic anhydrase II","volume":"117","author":"Pecina","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2023.106976_b0140","doi-asserted-by":"crossref","first-page":"19274","DOI":"10.1038\/s41598-020-76370-1","article-title":"In Vitro and in Vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells","volume":"10","author":"Alberti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.106976_b0145","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1021\/acs.molpharmaceut.3c00701","article-title":"The dawn of a new era: tumor-targeting boron agents for neutron capture therapy","volume":"20","author":"Luo","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2023.106976_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112460","article-title":"Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX","volume":"200","author":"Dvo\u0159anov\u00e1","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0155","doi-asserted-by":"crossref","first-page":"16541","DOI":"10.1002\/chem.202002809","article-title":"Direct introduction of an alkylsulfonamido group on C-sites of isomeric dicarba- closo -dodecaboranes: the influence of stereochemistry on inhibitory activity against the cancer-associated carbonic anhydrase IX isoenzyme","volume":"26","author":"Nekvinda","year":"2020","journal-title":"Chem. \u2013 Eur. J."},{"key":"10.1016\/j.bioorg.2023.106976_b0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2023.106976_b0165","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1080\/14756366.2020.1816996","article-title":"The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX","volume":"35","author":"Kugler","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0170","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1021\/acs.jmedchem.9b00945","article-title":"Metallacarborane sulfamides: unconventional, specific, and highly selective inhibitors of carbonic anhydrase IX","volume":"62","author":"Gr\u00fcner","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0175","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/elps.202000298","article-title":"Determination of acidity constants, ionic mobilities, and hydrodynamic radii of carborane-based inhibitors of carbonic anhydrases by capillary electrophoresis","volume":"42","author":"\u0160ol\u00ednov\u00e1","year":"2021","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bioorg.2023.106976_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.601820","article-title":"Boron neutron capture therapy: A review of clinical applications","volume":"11","author":"Malouff","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2023.106976_b0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2023.106976_b0190","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/jm7010589","article-title":"Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer","volume":"51","author":"Dorsey","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0195","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","article-title":"Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer","volume":"6","author":"Narra","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioorg.2023.106976_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112270","article-title":"Design and discovery of boronic acid drugs","volume":"195","author":"Plescia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/eurheartj\/ehy564.353","article-title":"Evaluation of the pharmacokinetics and pharmacodynamics of subcutaneously administered dutogliptin for daily injection with granulocyte colony stimulating factor (G-CSF) for AMI","volume":"39","author":"Nix","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioorg.2023.106976_b0210","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/1078-0432.CCR-06-0170","article-title":"United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy","volume":"12","author":"Kane","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106976_b0215","first-page":"217","article-title":"Spotlight on ixazomib: potential in the treatment of multiple myeloma","volume":"10","author":"Muz","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2023.106976_b0220","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.bmc.2016.10.023","article-title":"Bortezomib inhibits mammalian carbonic anhydrases","volume":"25","author":"Supuran","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0225","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.bmc.2016.07.035","article-title":"Bortezomib inhibits bacterial and fungal \u03b2-carbonic anhydrases","volume":"24","author":"Supuran","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0230","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaad.2018.05.1260","article-title":"Onychomycosis: Treatment and prevention of recurrence","volume":"80","author":"Lipner","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioorg.2023.106976_b0235","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaci.2019.06.047","article-title":"Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial","volume":"144","author":"Bissonnette","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bioorg.2023.106976_b0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/13543776.2018.1473379","article-title":"Benzoxaborole compounds for therapeutic uses: a patent review (2010\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.106976_b0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13543776.2023.2193328","article-title":"Emerging compounds and therapeutic strategies to treat infections from Trypanosoma brucei: an overhaul of the last 5-years patents","volume":"33","author":"Melfi","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.106976_b0250","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1021\/acs.jmedchem.7b00631","article-title":"Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)","volume":"60","author":"Li","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0255","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamadermatol.2019.0008","article-title":"Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: A systematic review and meta-analysis","volume":"155","author":"Yang","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioorg.2023.106976_b0260","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/acs.jmedchem.8b01719","article-title":"Design of N-benzoxaborole benzofuran GSK8175-optimization of human pharmacokinetics inspired by metabolites of a failed clinical HCV inhibitor","volume":"62","author":"Chong","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0265","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1039\/C6CC06399C","article-title":"Benzoxaborole as a new chemotype for carbonic anhydrase inhibition","volume":"52","author":"Alterio","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2023.106976_b0270","first-page":"1498","article-title":"Exploring benzoxaborole derivatives as carbonic anhydrase inhibitors: a structural and computational analysis reveals their conformational variability as a tool to increase enzyme selectivity","volume":"34","author":"Langella","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0275","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/acsmedchemlett.0c00403","article-title":"Benzoxaboroles: new potent inhibitors of the carbonic anhydrases of the pathogenic bacterium Vibrio cholerae","volume":"11","author":"Bonardi","year":"2020","journal-title":"ACS Med Chem Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0280","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/14756366.2017.1414808","article-title":"Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles","volume":"33","author":"Nocentini","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0285","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1021\/acsmedchemlett.7b00369","article-title":"Benzoxaboroles as efficient inhibitors of the \u03b2-carbonic anhydrases from pathogenic fungi: activity and modeling study","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0290","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/acsmedchemlett.9b00252","article-title":"Bis-benzoxaboroles: Design, synthesis, and biological evaluation as carbonic anhydrase inhibitors","volume":"10","author":"Larcher","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0295","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1002\/chem.201700241","article-title":"Effective access to multivalent inhibitors of carbonic anhydrases promoted by peptide bioconjugation","volume":"23","author":"Kanfar","year":"2017","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2023.106976_b0300","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1021\/acs.jmedchem.5b00383","article-title":"Poly(amidoamine) dendrimers with carbonic anhydrase inhibitory activity and antiglaucoma action","volume":"58","author":"Carta","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0305","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.3390\/ijms20215352","article-title":"Multivalent carbonic anhydrases inhibitors","volume":"20","author":"Carta","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106976_b0310","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1039\/C5OB01405K","article-title":"Emerging trends in enzyme inhibition by multivalent nanoconstructs","volume":"13","author":"Kanfar","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0315","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1021\/acs.jmedchem.3c00433","article-title":"6-Substituted triazolyl benzoxaboroles as selective carbonic anhydrase inhibitors. In silico design, synthesis, and X-ray crystallography","volume":"66","author":"Nocentini","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0320","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/14756366.2021.1972995","article-title":"An overview on the recently discovered iota-carbonic anhydrases","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0325","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-020-18425-5","article-title":"Elucidating the role of metal ions in carbonic anhydrase catalysis","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2023.106976_b0330","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2023.106976_b0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jinorgbio.2011.11.017","article-title":"(In)organic anions as carbonic anhydrase inhibitors","volume":"111","author":"De Simone","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2023.106976_b0340","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.bmc.2016.05.029","article-title":"Anion inhibition profiles of \u03b1-, \u03b2- and \u03b3-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae","volume":"24","author":"Del Prete","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/metabo10030093","article-title":"Anion inhibition studies of the \u03b2-class carbonic anhydrase CAS3 from the filamentous Ascomycete Sordaria macrospora","volume":"10","author":"Vullo","year":"2020","journal-title":"Metabolites."},{"key":"10.1016\/j.bioorg.2023.106976_b0350","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/pathogens5020044","article-title":"Legionella pneumophila carbonic anhydrases: underexplored antibacterial drug targets","volume":"5","author":"Supuran","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.bioorg.2023.106976_b0355","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2174\/1568026616666160413135522","article-title":"An overview of the carbonic anhydrases from two pathogens of the oral cavity: Streptococcus mutans and Porphyromonas gingivalis","volume":"16","author":"Capasso","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0360","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bmc.2016.11.021","article-title":"Anion inhibition profiles of the \u03b3-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics","volume":"25","author":"Del Prete","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0365","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1016\/j.bmc.2017.07.033","article-title":"Anion inhibitors of the \u03b2-carbonic anhydrase from the pathogenic bacterium responsible of tularemia, Francisella Tularensis","volume":"25","author":"Del Prete","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0370","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bmc.2016.01.005","article-title":"Cloning, characterization and anion inhibition studies of a \u03b3-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea","volume":"24","author":"De Luca","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0375","doi-asserted-by":"crossref","first-page":"2173748","DOI":"10.1080\/14756366.2023.2173748","article-title":"Inhibition studies with simple and complex (in)organic anions of the \u03b3-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri, MscCA\u03b3","volume":"38","author":"Giovannuzzi","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111274","article-title":"Inhibition of the newly discovered \u03b2-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with inorganic anions and small molecules","volume":"213","author":"Urba\u0144ski","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2023.106976_b0385","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bmcl.2010.11.124","article-title":"Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata","volume":"21","author":"Bertucci","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0390","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.3390\/ijms19072128","article-title":"Comparison of the anion inhibition profiles of the \u03b1-CA isoforms (SpiCA1, SpiCA2 and SpiCA3) from the scleractinian coral Stylophora pistillata","volume":"19","author":"Del Prete","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106976_b0395","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1016\/j.bmcl.2012.08.088","article-title":"The first activation study of a bacterial carbonic anhydrase (CA). The thermostable \u03b1-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines","volume":"22","author":"Vullo","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0400","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1016\/j.bmcl.2013.10.037","article-title":"Anion inhibition studies of a \u03b2-carbonic anhydrase from Clostridium perfringens","volume":"23","author":"Vullo","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0405","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jinorgbio.2012.02.009","article-title":"Inhibition of beta-carbonic anhydrases from the bacterial pathogen Brucella suis with inorganic anions","volume":"110","author":"Maresca","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2023.106976_b0410","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1016\/j.bmc.2015.05.029","article-title":"Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa","volume":"23","author":"Pinard","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0415","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/j.bmcl.2014.08.015","article-title":"Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum\u2013the \u03b7-carbonic anhydrases","volume":"24","author":"Del Prete","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0420","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bmcl.2011.12.085","article-title":"Anion inhibition studies of an \u03b1-carbonic anhydrase from the living fossil Astrosclera willeyana","volume":"22","author":"Ohradanova","year":"2012","journal-title":"Bioorg. Med. Chem Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0425","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bioorg.2017.12.009","article-title":"Protonography and anion inhibition profile of the \u03b1-carbonic anhydrase (CruCA4) identified in the Mediterranean red coral Corallium rubrum","volume":"76","author":"Del Prete","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0430","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1080\/14756366.2022.2080818","article-title":"Cloning, purification, kinetic and anion inhibition studies of a recombinant \u03b2-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris","volume":"37","author":"Aspatwar","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0435","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/14756366.2021.1931863","article-title":"An anion and small molecule inhibition study of the \u03b2-carbonic anhydrase from Staphylococcus aureus","volume":"36","author":"Urbanski","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/metabo10010039","article-title":"Sulfonamide Inhibition Profile of the \u03b2-Carbonic Anhydrase from Malassezia restricta, An Opportunistic Pathogen Triggering Scalp Conditions","volume":"10","author":"Del Prete","year":"2020","journal-title":"Metabolites."},{"key":"10.1016\/j.bioorg.2023.106976_b0445","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14756366.2017.1421182","article-title":"Anion inhibition studies of a beta carbonic anhydrase from the malaria mosquito Anopheles gambiae","volume":"33","author":"Vullo","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0450","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/molecules25112564","article-title":"Anion inhibition studies of the beta-carbonic anhydrase from Escherichia coli","volume":"25","author":"Del Prete","year":"2020","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2023.106976_b0455","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/14756366.2020.1867122","article-title":"Anion inhibition studies of the Zn(II)-bound \u03b9-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii","volume":"36","author":"Petreni","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0460","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/febs.12738","article-title":"Crystal structures of two tetrameric \u03b2-carbonic anhydrases from the filamentous ascomycete Sordaria macrospora","volume":"281","author":"Lehneck","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2023.106976_b0465","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14756366.2021.1929202","article-title":"Anion inhibition studies of the \u03b1-carbonic anhydrases from Neisseria gonorrhoeae","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0470","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.bmcl.2013.01.087","article-title":"Kinetic and anion inhibition studies of a \u03b2-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis","volume":"23","author":"Monti","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0475","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bmc.2013.10.045","article-title":"Cloning, characterization, and anion inhibition study of the \u03b4-class carbonic anhydrase (TweCA) from the marine diatom Thalassiosira weissflogii","volume":"22","author":"Del Prete","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0480","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bmcl.2010.01.081","article-title":"Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate","volume":"20","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0485","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/14756366.2014.918610","article-title":"Dipotassium-trioxohydroxytetrafluorotriborate, K\u2082[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases","volume":"30","author":"Vullo","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0490","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/14756366.2022.2072837","article-title":"The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX","volume":"37","author":"Yusuf","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0495","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360701425014","article-title":"The role of fluorine in medicinal chemistry","volume":"22","author":"Shah","year":"2007","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0500","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3109\/14756366.2015.1078329","article-title":"Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line","volume":"31","author":"Pojskic","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106976_b0505","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jclinpath-2018-205653","article-title":"TERT gene: its function and dysregulation in cancer","volume":"72","author":"Colebatch","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bioorg.2023.106976_b0510","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2004.06.001","article-title":"Boric acid inhibits human prostate cancer cell proliferation","volume":"216","author":"Barranco","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2023.106976_b0515","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12011-007-8081-8","article-title":"Comparative effects of boric acid and calcium fructoborate on breast cancer cells","volume":"122","author":"Scorei","year":"2008","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.bioorg.2023.106976_b0520","article-title":"Boric acid as a promising agent in the treatment of ovarian cancer: Molecular mechanisms","volume":"796\u2013797","author":"Cabus","year":"2021","journal-title":"Gene."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:47:46Z","timestamp":1758617266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823006375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":104,"alternative-id":["S0045206823006375"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106976","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Boron-containing carbonic anhydrases inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106976"}}